PNC-27 (5mg)
$140.00
Discover PNC-27 (5mg), a synthetic peptide engineered to target cancer cells while sparing healthy tissues. This innovative peptide binds to malformed cells, promoting necrosis for potential cancer treatment.
Overview
PNC-27 (5mg) is a synthetic peptide designed specifically for its potential role in inhibiting cancer cell proliferation. Developed to selectively attach to cancerous cells, PNC-27 initiates a process that leads to cell death while avoiding damage to normal cells. This targeted approach could offer a promising avenue for future cancer therapies.
Key Features
- Synthetic peptide targeting cancerous cells
- Designed to promote necrosis in malignancies
- Contains the HDM2 binding domain and transmembrane domain from p53
- Potential therapeutic applications in oncology
- 5mg dosage for optimal effectiveness
Specifications
| Property | Details |
|---|---|
| Product Name | PNC-27 |
| Dosage | 5mg |
| Type | Synthetic Peptide |
FAQ
What is PNC-27 used for?
PNC-27 is primarily researched for its ability to inhibit cancer cell growth by targeting malformed cells. Researchers are exploring its potential as a therapeutic agent in cancer treatment.
How does PNC-27 work?
This peptide binds to cancer cells through specific domains and induces cell death while leaving healthy cells unharmed, making it a promising candidate for targeted cancer therapies.
Where can I find more peptides?
If you’re interested in exploring other peptides, check out our selection of Biotech Peptidesincluding N-Acetyl Selank and Vialox, for varied applications.
Investing in PNC-27 is a step toward exploring advanced treatment options. If you’re looking for an effective peptide that targets cancer directly, consider adding PNC-27 (5mg) to your regimen today.
Related Products
Related products
